Treatment options for postural instability and gait difficulties in Parkinson’s disease

References

• Lopez IC, Ruiz PJ, Del Pozo SV, et al. Motor complications in Parkinson’s disease: ten year follow-up study. Mov Disord. 2010 Dec 15;25(16):2735–2739.
   PubMed Web of Science ®Google Scholar
• Vu TC, Nutt JG, Holford NH. Progression of motor and nonmotor features of Parkinson’s disease and their response to treatment. Br J Clin Pharmacol. 2012 Aug;74(2):267–283.
   PubMed Web of Science ®Google Scholar
• Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014 Apr;71(4):499–504.
   PubMed Web of Science ®Google Scholar
• Obeso JA, Stamelou M, Goetz CG, et al. Past, present, and future of Parkinson’s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord. 2017 Sep;32(9):1264–1310.
   PubMed Web of Science ®Google Scholar
• Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology. 2001 Jun 26;56(12):1712–1721.
   PubMed Web of Science ®Google Scholar
• Ferraye MU, Debu B, Pollak P. Deep brain stimulation effect on freezing of gait. Mov Disord. 2008;23(Suppl 2):S489–94.
   PubMedGoogle Scholar
• Devos D, Defebvre L, Bordet R. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease. Fundam Clin Pharmacol. 2010 Aug;24(4):407–421.
   PubMed Web of Science ®Google Scholar
• Lamont RM, Morris ME, Menz HB, et al. Falls in people with Parkinson’s disease: a prospective comparison of community and home-based falls. Gait Posture. 2017;55:62–67.
   PubMed Web of Science ®Google Scholar
• Hely MA, Morris JG, Reid WG, et al. Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005 Feb;20(2):190–199.
   PubMed Web of Science ®Google Scholar
• Williams-Gray CH, Mason SL, Evans JR, et al. The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1258–1264.
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Jahn K. Imaging: what can it tell us about parkinsonian gait? Mov Disord. 2013 Sep 15;28(11):1492–1500.
   PubMed Web of Science ®Google Scholar
• Mirelman A, Bonato P, Camicioli R, et al. Gait impairments in Parkinson’s disease. Lancet Neurol. 2019 Jul;18(7):697–708.
   PubMed Web of Science ®Google Scholar
• Snijders AH, Takakusaki K, Debu B, et al. Physiology of freezing of gait. Ann Neurol. 2016 Nov;80(5):644–659.
   PubMed Web of Science ®Google Scholar
• Naismith SL, Lewis SJ. A novel paradigm for modelling freezing of gait in Parkinson’s disease. J Clin Neurosci. 2010 Aug;17(8):984–987.
   PubMed Web of Science ®Google Scholar
• Shine JM, Naismith SL, Lewis SJ. The pathophysiological mechanisms underlying freezing of gait in Parkinson’s Disease. J Clin Neurosci. 2011 Sep;18(9):1154–1157.
   PubMed Web of Science ®Google Scholar
• Bekkers EMJ, Dijkstra BW, Heremans E, et al. Balancing between the two: are freezing of gait and postural instability in Parkinson’s disease connected? Neurosci Biobehav Rev. 2018;94:113–125.
   PubMed Web of Science ®Google Scholar
• Park JH, Kang YJ, Horak FB. What is wrong with balance in Parkinson’s disease? J Mov Disord. 2015 Sep;8(3):109–114.
   PubMed Web of Science ®Google Scholar
• Bartels AL, Leenders KL. Brain imaging in patients with freezing of gait. Mov Disord. 2008;23(Suppl 2):S461–7.
   PubMedGoogle Scholar
• Snijders AH, Leunissen I, Bakker M, et al. Gait-related cerebral alterations in patients with Parkinson’s disease with freezing of gait. Brain. 2011 Jan;134(Pt 1):59–72.
   PubMed Web of Science ®Google Scholar
• Tessitore A, Amboni M, Esposito F, et al. Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait. Parkinsonism Relat Disord. 2012 Jul;18(6):781–787.
   PubMed Web of Science ®Google Scholar
• Caggiano V, Leiras R, Goni-Erro H, et al. Midbrain circuits that set locomotor speed and gait selection. Nature. 2018 Jan 25;553(7689):455–460.
   PubMed Web of Science ®Google Scholar
• Canu E, Agosta F, Sarasso E, et al. Brain structural and functional connectivity in Parkinson’s disease with freezing of gait. Hum Brain Mapp. 2015 Dec;36(12):5064–5078.
   PubMed Web of Science ®Google Scholar
• Vandenbossche J, Deroost N, Soetens E, et al. Freezing of gait in Parkinson’s disease: disturbances in automaticity and control. Front Hum Neurosci. 2012;6:356.
   PubMed Web of Science ®Google Scholar
• Shine JM, Matar E, Ward PB, et al. Freezing of gait in Parkinson’s disease is associated with functional decoupling between the cognitive control network and the basal ganglia. Brain. 2013 Dec;136(Pt 12):3671–3681.
   PubMedGoogle Scholar
• Bharti K, Suppa A, Pietracupa S, et al. Aberrant functional connectivity in patients with Parkinson’s disease and freezing of gait: a within- and between-network analysis. Brain Imaging Behav. 2019 Mar;19. [Epub ahead of print].
   Google Scholar
• Fling BW, Cohen RG, Mancini M, et al. Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait. Brain. 2013 Aug;136(Pt 8):2405–2418.
   PubMed Web of Science ®Google Scholar
• Gilat M, Dijkstra BW, D’Cruz N, et al. Functional MRI to study gait impairment in Parkinson’s disease: a systematic review and exploratory ALE meta-analysis. Curr Neurol Neurosci Rep. 2019 Jun 18;19(8):49.
   PubMed Web of Science ®Google Scholar
• Bharti K, Suppa A, Pietracupa S, et al. Abnormal cerebellar connectivity patterns in patients with parkinson’s disease and freezing of gait. Cerebellum. 2019 Jun;18(3):298–308.
   PubMed Web of Science ®Google Scholar
• Kucinski A, Albin RL, Lustig C, et al. Modeling falls in Parkinson’s disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss. Behav Brain Res. 2015 Apr;1(282):155–164.
   Google Scholar
• Perez-Lloret S, Negre-Pages L, Damier P, et al. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. JAMA Neurol. 2014 Jul 1;71(7):884–890.
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Frey KA, Studenski S, et al. Extra-nigral pathological conditions are common in Parkinson’s disease with freezing of gait: an in vivo positron emission tomography study. Mov Disord. 2014 Aug;29(9):1118–1124.
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Kanel P, Zhou Z, et al. Cholinergic system changes of falls and freezing of gait in Parkinson’s disease. Ann Neurol. 2019 Apr;85(4):538–549.
   PubMed Web of Science ®Google Scholar
• Sarter M, Albin RL, Kucinski A, et al. Where attention falls: increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Exp Neurol. 2014 Jul;257:120–129.
   PubMed Web of Science ®Google Scholar
• Boecker H. Imaging the role of GABA in movement disorders. Curr Neurol Neurosci Rep. 2013 Oct;13(10):385.
   PubMed Web of Science ®Google Scholar
• Nambu A. A new dynamic model of the cortico-basal ganglia loop. Prog Brain Res. 2004;143:461–466.
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Barker RA. A pathophysiological model of freezing of gait in Parkinson’s disease. Parkinsonism Relat Disord. 2009 Jun;15(5):333–338.
   PubMed Web of Science ®Google Scholar
• Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 1991 Apr 26;547(1):142–151.
   PubMed Web of Science ®Google Scholar
• Vila M, Levy R, Herrero MT, et al. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci. 1997 Jan 15;17(2):765–773.
   PubMed Web of Science ®Google Scholar
• Takakusaki K, Habaguchi T, Ohtinata-Sugimoto J, et al. Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction. Neuroscience. 2003;119(1):293–308.
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Shine JM. The next step: a common neural mechanism for freezing of gait. Neuroscientist. 2016 Feb;22(1):72–82.
   PubMed Web of Science ®Google Scholar
• Ashburn A, Stack E, Ballinger C, et al. The circumstances of falls among people with Parkinson’s disease and the use of Falls Diaries to facilitate reporting. Disabil Rehabil. 2008;30(16):1205–1212.
   PubMed Web of Science ®Google Scholar
• Rudzinska M, Bukowczan S, Stozek J, et al. Causes and consequences of falls in Parkinson disease patients in a prospective study. Neurol Neurochir Pol. 2013 Sep-Oct;47(5):423–430.
   PubMed Web of Science ®Google Scholar
• Gazibara T, Kisic-Tepavcevic D, Svetel M, et al. Indoor and outdoor falls in persons with Parkinson’s disease after 1 year follow-up study: differences and consequences. Neurol Sci. 2016 Apr;37(4):597–602.
   PubMed Web of Science ®Google Scholar
• Muller ML, Albin RL, Kotagal V, et al. Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease. Brain. 2013 Nov;136(Pt 11):3282–3289.
   PubMedGoogle Scholar
• Bohnen NI, Muller ML, Koeppe RA, et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 2009 Nov 17;73(20):1670–1676.
   PubMed Web of Science ®Google Scholar
• Karachi C, Grabli D, Bernard FA, et al. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest. 2010 Aug;120(8):2745–2754.
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Muller M, Dauer WT, et al. Parkinson’s Disease: what role do pedunculopontine nucleus cholinergic neurons play? Future Neurol. 2014 Jan;9(1):5–8.
   PubMedGoogle Scholar
• Diaz-Hernandez E, Contreras-Lopez R, Sanchez-Fuentes A, et al. The thalamostriatal projections contribute to the initiation and execution of a sequence of movements. Neuron. 2018 Nov 7;100(3):739–752 e5.
   PubMed Web of Science ®Google Scholar
• Xie T, Kang UJ, Kuo SH, et al. Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center. NPJ Parkinson’s Dis. 2015;1:15007.
   PubMed Web of Science ®Google Scholar
• Bhidayasiri R, Riley DE, Somers JT, et al. Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology. 2001 Dec 11;57(11):2070–2077.
   PubMed Web of Science ®Google Scholar
• Pinkhardt EH, Kassubek J. Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism Relat Disord. 2011 May;17(4):223–230.
   PubMed Web of Science ®Google Scholar
• Eisinger RS, Hess CW, Martinez-Ramirez D, et al. Motor subtype changes in early Parkinson’s disease. Parkinsonism Relat Disord. 2017 Oct;43(Supplement C):67–72.
   PubMedGoogle Scholar
• Fereshtehnejad SM, Romenets SR, Anang JB, et al. New clinical subtypes of parkinson disease and their longitudinal progression: a prospective Cohort comparison with other phenotypes. JAMA Neurol. 2015 Aug;72(8):863–873.
   PubMed Web of Science ®Google Scholar
• Hirsch EC, Graybiel AM, Duyckaerts C, et al. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5976–5980.
   PubMed Web of Science ®Google Scholar
• Skorvanek M, Gdovinova Z, Rosenberger J, et al. The associations between fatigue, apathy, and depression in Parkinson’s disease. Acta Neurol Scand. 2015 Feb;131(2):80–87.
   PubMed Web of Science ®Google Scholar
• Benka Wallen M, Franzen E, Nero H, et al. Levels and patterns of physical activity and sedentary behavior in elderly people with mild to moderate Parkinson disease. Phys Ther. 2015 Aug;95(8):1135–1141.
   PubMed Web of Science ®Google Scholar
• Lord S, Godfrey A, Galna B, et al. Ambulatory activity in incident Parkinson’s: more than meets the eye? J Neurol. 2013 Dec;260(12):2964–2972.
   PubMed Web of Science ®Google Scholar
• van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, et al. Physical inactivity in Parkinson’s disease. J Neurol. 2011 Dec;258(12):2214–2221.
   PubMed Web of Science ®Google Scholar
• Speelman AD, van de Warrenburg BP, van Nimwegen M, et al. How might physical activity benefit patients with Parkinson disease? Nat Rev Neurol. 2011 Jul 12;7(9):528–534.
   PubMed Web of Science ®Google Scholar
• Hirsch MA, Toole T, Maitland CG, et al. The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson’s disease. Arch Phys Med Rehabil. 2003 Aug;84(8):1109–1117.
   PubMed Web of Science ®Google Scholar
• Boelen M. The role of rehabilitative modalities and exercise in Parkinson’s disease. Dis Mon. 2007 May;53(5):259–264.
   PubMedGoogle Scholar
• Shulman LM, Katzel LI, Ivey FM, et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol. 2013 Feb;70(2):183–190.
   PubMed Web of Science ®Google Scholar
• Ellis T, Cavanaugh JT, Earhart GM, et al. Factors associated with exercise behavior in people with Parkinson disease. Phys Ther. 2011 Dec;91(12):1838–1848.
   PubMed Web of Science ®Google Scholar
• Ekblom-Bak E, Ekblom B, Vikstrom M, et al. The importance of non-exercise physical activity for cardiovascular health and longevity. Br J Sports Med. 2014 Feb;48(3):233–238.
   PubMed Web of Science ®Google Scholar
• Snider J, Muller ML, Kotagal V, et al. Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration. Parkinsonism Relat Disord. 2015 Oct;21(10):1227–1231.
   PubMed Web of Science ®Google Scholar
• van Nimwegen M, Speelman AD, Smulders K, et al. Design and baseline characteristics of the ParkFit study, a randomized controlled trial evaluating the effectiveness of a multifaceted behavioral program to increase physical activity in Parkinson patients. BMC Neurol. 2010 Aug;19(10):70.
   Google Scholar
• van Nimwegen M, Speelman AD, Overeem S, et al. Promotion of physical activity and fitness in sedentary patients with Parkinson’s disease: randomised controlled trial. BMJ. 2013 Mar;1(346):f576.
   Google Scholar
• van der Kolk NM, van Nimwegen M, Speelman AD, et al. A personalized coaching program increases outdoor activities and physical fitness in sedentary Parkinson patients; a post-hoc analysis of the ParkFit trial. Parkinsonism Relat Disord. 2014 Dec;20(12):1442–1444.
   PubMed Web of Science ®Google Scholar
• Speelman AD, van Nimwegen M, Bloem BR, et al. Evaluation of implementation of the ParkFit program: a multifaceted intervention aimed to promote physical activity in patients with Parkinson’s disease. Physiotherapy. 2014 Jun;100(2):134–141.
   PubMed Web of Science ®Google Scholar
• Bhalsing KS, Abbas MM, Tan LCS. Role of physical activity in Parkinson’s disease. Ann Indian Acad Neurol. 2018 Oct-Dec;21(4):242–249.
   PubMed Web of Science ®Google Scholar
• Ahlskog JE. Aerobic exercise: evidence for a direct brain effect to slow Parkinson disease progression. Mayo Clin Proc. 2018 Mar;93(3):360–372.
   PubMed Web of Science ®Google Scholar
• Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology. 2011 Jul 19;77(3):288–294.
   PubMed Web of Science ®Google Scholar
• Shen X, Wong-Yu IS, Mak MK. Effects of exercise on falls, balance, and gait ability in Parkinson’s disease: a meta-analysis. Neurorehabil Neural Repair. 2016 Jul;30(6):512–527.
   PubMed Web of Science ®Google Scholar
• Flach A, Jaegers L, Krieger M, et al. Endurance exercise improves function in individuals with Parkinson’s disease: a meta-analysis. Neurosci Lett. 2017 Oct 17;659(Supplement C):115–119.
   PubMedGoogle Scholar
• Uhrbrand A, Stenager E, Pedersen MS, et al. Parkinson’s disease and intensive exercise therapy–a systematic review and meta-analysis of randomized controlled trials. J Neurol Sci. 2015 Apr 14;353(1–2):9–19.
   PubMed Web of Science ®Google Scholar
• Goodwin VA, Richards SH, Taylor RS, et al. The effectiveness of exercise interventions for people with Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2008 Apr 15;23(5):631–640.
   PubMed Web of Science ®Google Scholar
• Corcos DM, Robichaud JA, David FJ, et al. A two-year randomized controlled trial of progressive resistance exercise for Parkinson’s disease. Mov Disord. 2013 Aug;28(9):1230–1240.
   PubMed Web of Science ®Google Scholar
• Prodoehl J, Rafferty MR, David FJ, et al. Two-year exercise program improves physical function in Parkinson’s disease: the PRET-PD randomized clinical trial. Neurorehabil Neural Repair. 2015 Feb;29(2):112–122.
   PubMed Web of Science ®Google Scholar
• Rafferty MR, Prodoehl J, Robichaud JA, et al. Effects of 2 years of exercise on gait impairment in people with Parkinson disease: the PRET-PD randomized trial. J Neurol Phys Ther. 2017 Jan;41(1):21–30.
   PubMed Web of Science ®Google Scholar
• Santos L, Fernandez-Rio J, Winge K, et al. Effects of progressive resistance exercise in akinetic-rigid Parkinson’s disease patients: a randomized controlled trial. Eur J Phys Rehabil Med. 2017 Oct;53(5):651–663.
   PubMed Web of Science ®Google Scholar
• Uc EY, Doerschug KC, Magnotta V, et al. Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting. Neurology. 2014 Jul 29;83(5):413–425.
   PubMed Web of Science ®Google Scholar
• Shu HF, Yang T, Yu SX, et al. Aerobic exercise for Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2014;9(7):e100503.
   PubMed Web of Science ®Google Scholar
• Schenkman M, Moore CG, Kohrt WM, et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with De Novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol. 2018 Feb 1;75(2):219–226.
   PubMed Web of Science ®Google Scholar
• Ellis T, Boudreau JK, DeAngelis TR, et al. Barriers to exercise in people with Parkinson disease. Phys Ther. 2013 May;93(5):628–636.
   PubMed Web of Science ®Google Scholar
• Quinn L, Busse M, Khalil H, et al. Client and therapist views on exercise programmes for early-mid stage Parkinson’s disease and Huntington’s disease. Disabil Rehabil. 2010;32(11):917–928.
   PubMed Web of Science ®Google Scholar
• Hall DA, Moore C, Comella C, et al. Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial. Trials. 2018 Nov 14;19(1):630.
   PubMedGoogle Scholar
• Abbruzzese G, Marchese R, Avanzino L, et al. Rehabilitation for Parkinson’s disease: current outlook and future challenges. Parkinsonism Relat Disord. 2016 Jan;22(Suppl 1):S60–4.
   PubMed Web of Science ®Google Scholar
• Domingos J, Keus SHJ, Dean J, et al. The European physiotherapy guideline for Parkinson’s disease: implications for neurologists. J Parkinsons Dis. 2018;8(4):499–502.
   PubMedGoogle Scholar
• Kwakkel G, de Goede CJ, van Wegen EE. Impact of physical therapy for Parkinson’s disease: a critical review of the literature. Parkinsonism Relat Disord. 2007;13(Suppl 3):S478–87.
   PubMedGoogle Scholar
• Tomlinson CL, Patel S, Meek C, et al. Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis. BMJ. 2012 Aug;6(345):e5004.
   Google Scholar
• Tomlinson CL, Patel S, Meek C, et al. Physiotherapy versus placebo or no intervention in Parkinson’s disease. Cochrane Database Syst Rev. 2013 Sep;10(9):CD002817.
   Google Scholar
• Tomlinson CL, Herd CP, Clarke CE, et al. Physiotherapy for Parkinson’s disease: a comparison of techniques. Cochrane Database Syst Rev. 2014 Jun;17(6):CD002815.
   Google Scholar
• Keus SH, Nijkrake MJ, Borm GF, et al. The ParkinsonNet trial: design and baseline characteristics. Mov Disord. 2010 May 15;25(7):830–837.
   PubMed Web of Science ®Google Scholar
• Nijkrake MJ, Keus SH, Overeem S, et al. The ParkinsonNet concept: development, implementation and initial experience. Mov Disord. 2010 May 15;25(7):823–829.
   PubMed Web of Science ®Google Scholar
• Munneke M, Nijkrake MJ, Keus SH, et al. Efficacy of community-based physiotherapy networks for patients with Parkinson’s disease: a cluster-randomised trial. Lancet Neurol. 2010 Jan;9(1):46–54.
   PubMed Web of Science ®Google Scholar
• Sturkenboom IH, Graff MJ, Hendriks JC, et al. Efficacy of occupational therapy for patients with Parkinson’s disease: a randomised controlled trial. Lancet Neurol. 2014 Jun;13(6):557–566.
   PubMed Web of Science ®Google Scholar
• Ypinga JHL, de Vries NM, Boonen L, et al. Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data. Lancet Neurol. 2018 Feb;17(2):153–161.
   PubMed Web of Science ®Google Scholar
• Clarke CE, Patel S, Ives N, et al. Physiotherapy and occupational therapy vs no therapy in mild to moderate Parkinson disease: a randomized clinical trial. JAMA Neurol. 2016 Mar;73(3):291–299.
   PubMed Web of Science ®Google Scholar
• Clarke CE, Walker MF, Sackley CM. Physiotherapy and occupational therapy and mild to moderate Parkinason disease-reply. JAMA Neurol. 2016 Jul 1;73(7):894–895.
   PubMed Web of Science ®Google Scholar
• Mak MK, Wong-Yu IS, Shen X, et al. Long-term effects of exercise and physical therapy in people with Parkinson disease. Nat Rev Neurol. 2017 Nov;13(11):689–703.
   PubMed Web of Science ®Google Scholar
• Vina J, Sanchis-Gomar F, Martinez-Bello V, et al. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol. 2012 Sep;167(1):1–12.
   PubMed Web of Science ®Google Scholar
• Ni M, Hazzard JB, Signorile JF, et al. Exercise guidelines for gait function in Parkinson’s disease: a systematic review and meta-analysis. Neurorehabil Neural Repair. 2018 Oct;32(10):872–886.
   PubMed Web of Science ®Google Scholar
• Fishel SC, Hotchkiss ME, Brown SA. The impact of LSVT BIG therapy on postural control for individuals with Parkinson disease: a case series. Physiother Theory Pract. 2018 Aug;17:1–9.
   Google Scholar
• Janssens J, Malfroid K, Nyffeler T, et al. Application of LSVT BIG intervention to address gait, balance, bed mobility, and dexterity in people with Parkinson disease: a case series. Phys Ther. 2014 Jul;94(7):1014–1023.
   PubMed Web of Science ®Google Scholar
• Frazzitta G, Maestri R, Bertotti G, et al. Intensive rehabilitation treatment in early Parkinson’s disease: a randomized pilot study with a 2-year follow-up. Neurorehabil Neural Repair. 2015 Feb;29(2):123–131.
   PubMed Web of Science ®Google Scholar
• Bloem BR, Rompen L, Vries NM, et al. ParkinsonNet: a low-cost health care innovation with a systems approach from the Netherlands. Health Aff. 2017 Nov;36(11):1987–1996. (Millwood).
   PubMed Web of Science ®Google Scholar
• Atterbury EM, Welman KE. Balance training in individuals with Parkinson’s disease: therapist-supervised vs. home-based exercise programme. Gait Posture. 2017 Jun;55:138–144.
   PubMed Web of Science ®Google Scholar
• King LA, Wilhelm J, Chen Y, et al. Effects of group, individual, and home exercise in persons with Parkinson disease: a randomized clinical trial. J Neurol Phys Ther. 2015 Oct;39(4):204–212.
   PubMed Web of Science ®Google Scholar
• Aguiar LPC, Da Rocha PA, Morris M. Therapeutic dancing for Parkinson’s disease. Int J Gerontol. 2016 Jun;10(2):64–70.
   Web of Science ®Google Scholar
• Kalyani HHN, Sullivan K, Moyle G, et al. Effects of dance on gait, cognition, and dual-tasking in Parkinson’s disease: a systematic review and meta-analysis. J Parkinsons Dis. 2019;9(2):335–349.
   PubMedGoogle Scholar
• Rios Romenets S, Anang J, Fereshtehnejad SM, et al. Tango for treatment of motor and non-motor manifestations in Parkinson’s disease: a randomized control study. Complement Ther Med. 2015 Apr;23(2):175–184.
   PubMed Web of Science ®Google Scholar
• Rawson KS, McNeely ME, Duncan RP, et al. Exercise and Parkinson disease: comparing tango, treadmill, and stretching. J Neurol Phys Ther. 2019 Jan;43(1):26–32.
   PubMed Web of Science ®Google Scholar
• Solla P, Cugusi L, Bertoli M, et al. Sardinian folk dance for individuals with Parkinson’s disease: a randomized controlled pilot trial. J Altern Complement Med. 2019 Mar;25(3):305–316.
   PubMed Web of Science ®Google Scholar
• Shanahan J, Morris ME, Bhriain ON, et al. Dancing for Parkinson disease: a randomized trial of Irish set dancing compared with usual care. Arch Phys Med Rehabil. 2017 Sep;98(9):1744–1751.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim SY, Chae Y, et al. Turo (Qi Dance) program for Parkinson’s disease patients: randomized, assessor blind, waiting-list control, partial crossover study. Explore. 2018 May - Jun;14(3):216–223. (New York, NY).
   Google Scholar
• Rocha PA, Slade SC, McClelland J, et al. Dance is more than therapy: qualitative analysis on therapeutic dancing classes for Parkinson’s. Complement Ther Med. 2017;34:1–9.
   PubMed Web of Science ®Google Scholar
• Snijders AH, Haaxma CA, Hagen YJ, et al. Freezer or non-freezer: clinical assessment of freezing of gait. Parkinsonism Relat Disord. 2012 Feb;18(2):149–154.
   PubMed Web of Science ®Google Scholar
• Song R, Grabowska W, Park M, et al. The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2017;41:3–13.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li XY, Gong L, et al. Tai Chi for improvement of motor function, balance and gait in Parkinson’s disease: a systematic review and meta-analysis. PLoS One. 2014;9(7):e102942.
   PubMed Web of Science ®Google Scholar
• Ni X, Liu S, Lu F, et al. Efficacy and safety of Tai Chi for Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2014;9(6):e99377.
   PubMed Web of Science ®Google Scholar
• Liu HH, Yeh NC, Wu YF, et al. Effects of Tai Chi exercise on reducing falls and improving balance performance in Parkinson’s disease: a meta-analysis. Parkinsons Dis. 2019;2019:9626934.
   PubMedGoogle Scholar
• Wilson TL. Rock steady boxing: fighting Parkinson’s disease one counter punch at a time. Palaestra. 2018;32:1.
   Web of Science ®Google Scholar
• Combs SA, Diehl MD, Staples WH, et al. Boxing training for patients with Parkinson disease: a case series. Phys Ther. 2011 Jan;91(1):132–142.
   PubMed Web of Science ®Google Scholar
• Honda T, Kamioka H. Curative and health enhancement effects of aquatic exercise: evidence based on interventional studies. Open Access J Sports Med. 2012;3:27–34.
   PubMedGoogle Scholar
• Palamara G, Gotti F, Maestri R, et al. Land plus aquatic therapy versus land-based rehabilitation alone for the treatment of balance dysfunction in Parkinson disease: a randomized controlled study with 6-month follow-up. Arch Phys Med Rehabil. 2017 Jun;98(6):1077–1085.
   PubMed Web of Science ®Google Scholar
• Kurt EE, Buyukturan B, Buyukturan O, et al. Effects of Ai Chi on balance, quality of life, functional mobility, and motor impairment in patients with Parkinson’s disease. Disabil Rehabil. 2018 Apr;40(7):791–797.
   PubMed Web of Science ®Google Scholar
• Volpe D, Giantin MG, Maestri R, et al. Comparing the effects of hydrotherapy and land-based therapy on balance in patients with Parkinson’s disease: a randomized controlled pilot study. Clin Rehabil. 2014 Dec;28(12):1210–1217.
   PubMed Web of Science ®Google Scholar
• Volpe D, Giantin MG, Manuela P, et al. Water-based vs. non-water-based physiotherapy for rehabilitation of postural deformities in Parkinson’s disease: a randomized controlled pilot study. Clin Rehabil. 2017 Aug;31(8):1107–1115.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Yin M, Cui L, et al. Aquatic obstacle training improves freezing of gait in Parkinson’s disease patients: a randomized controlled trial. Clin Rehabil. 2018 Jan;32(1):29–36.
   PubMed Web of Science ®Google Scholar
• Terrens AF, Soh SE, Morgan PE. The efficacy and feasibility of aquatic physiotherapy for people with Parkinson’s disease: a systematic review. Disabil Rehabil. 2018 Dec;40(24):2847–2856.
   PubMed Web of Science ®Google Scholar
• Cugusi L, Manca A, Bergamin M, et al. Aquatic exercise improves motor impairments in people with Parkinson’s disease, with similar or greater benefits than land-based exercise: a systematic review. J Physiother. 2019 Apr;65(2):65–74.
   PubMed Web of Science ®Google Scholar
• Baltadjieva R, Giladi N, Gruendlinger L, et al. Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson’s disease. Eur J Neurosci. 2006 Sep;24(6):1815–1820.
   PubMed Web of Science ®Google Scholar
• Blin O, Ferrandez AM, Pailhous J, et al. Dopa-sensitive and dopa-resistant gait parameters in Parkinson’s disease. J Neurol Sci. 1991 May;103(1):51–54.
   PubMed Web of Science ®Google Scholar
• Bloem BR, Steijns JA, Smits-Engelsman BC. An update on falls. Curr Opin Neurol. 2003 Feb;16(1):15–26.
   PubMed Web of Science ®Google Scholar
• Smulders K, Dale ML, Carlson-Kuhta P, et al. Pharmacological treatment in Parkinson’s disease: effects on gait. Parkinsonism Relat Disord. 2016;31:3–13.
   PubMed Web of Science ®Google Scholar
• Curtze C, Nutt JG, Carlson-Kuhta P, et al. Levodopa is a double-edged sword for balance and gait in people with Parkinson’s disease. Mov Disord. 2015 Sep;30(10):1361–1370.
   PubMed Web of Science ®Google Scholar
• Ikeda K, Hirayama T, Takazawa T, et al. Transdermal patch of rotigotine attenuates freezing of gait in patients with Parkinson’s disease: an open-label comparative study of three non-ergot dopamine receptor agonists. Intern Med. 2016;55(19):2765–2769.
   PubMed Web of Science ®Google Scholar
• Chung KA, Lobb BM, Nutt JG, et al. Cholinergic augmentation in frequently fallings subjects with Parkinson’s disease. Mov Disord. 2009;24(Suppl 1):S259.
   Google Scholar
• Henderson EJ, Morgan GS, Amin J, et al. The minimum clinically important difference (MCID) for a falls intervention in Parkinson’s: A delphi study. Parkinsonism Relat Disord. 2019;61:106–110.
   PubMed Web of Science ®Google Scholar
• Li Z, Yu Z, Zhang J, et al. Impact of rivastigmine on cognitive dysfunction and falling in Parkinson’s disease patients. Eur Neurol. 2015;74(1–2):86–91.
   PubMed Web of Science ®Google Scholar
• Yarnall A, Rochester L, Burn DJ. The interplay of cholinergic function, attention, and falls in Parkinson’s disease. Mov Disord. 2011 Dec;26(14):2496–2503.
   PubMed Web of Science ®Google Scholar
• Chung KA, Lobb BM, Nutt JG, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. 2010 Oct 5;75(14):1263–1269.
   PubMed Web of Science ®Google Scholar
• Henderson EJ, Lord SR, Brodie MA, et al. Rivastigmine for gait stability in patients with Parkinson’s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2016 Mar;15(3):249–258.
   PubMed Web of Science ®Google Scholar
• Litvinenko IV, Odinak MM, Mogil’naya VI, et al. Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson’s disease (an open controlled trial). Neurosci Behav Physiol. 2008 Nov;38(9):937–945.
   PubMedGoogle Scholar
• Pollak L, Dobronevsky Y, Prohorov T, et al. Low dose methylphenidate improves freezing in advanced Parkinson’s disease during off-state. J Neural Transm Suppl. 2007;72:145–148.
   PubMed Web of Science ®Google Scholar
• Devos D, Krystkowiak P, Clement F, et al. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007 May;78(5):470–475.
   PubMed Web of Science ®Google Scholar
• Auriel E, Hausdorff JM, Herman T, et al. Effects of methylphenidate on cognitive function and gait in patients with Parkinson’s disease: a pilot study. Clin Neuropharmacol. 2006 Jan-Feb;29(1):15–17.
   PubMed Web of Science ®Google Scholar
• Nutt JG, Carter JH, Carlson NE. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial. Arch Neurol. 2007 Mar;64(3):319–323.
   PubMedGoogle Scholar
• Auriel E, Hausdorff JM, Giladi N. Methylphenidate for the treatment of Parkinson disease and other neurological disorders. Clin Neuropharmacol. 2009 Mar-Apr;32(2):75–81.
   PubMed Web of Science ®Google Scholar
• Espay AJ, Dwivedi AK, Payne M, et al. Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial. Neurology. 2011 Apr 5;76(14):1256–1262.
   PubMed Web of Science ®Google Scholar
• Moreau C, Delval A, Defebvre L, et al. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol. 2012 Jul;11(7):589–596.
   PubMed Web of Science ®Google Scholar
• Jankovic J. Atomoxetine for freezing of gait in Parkinson disease. J Neurol Sci. 2009 Sep 15;284(1–2):177–178.
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Norcliffe-Kaufmann L, Palma JA. Droxidopa in neurogenic orthostatic hypotension. Expert Rev Cardiovasc Ther. 2015;13(8):875–891.
   PubMed Web of Science ®Google Scholar
• Kondo T. Treatment of Parkinson’s disease in Japan. Parkinsonism Relat Disord. 2000 Nov 1;7(1):71–77.
   PubMed Web of Science ®Google Scholar
• Tohgi H, Abe T, Takahashi S. The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients. J Neural Transm Park Dis Dement Sect. 1993;5(1):27–34.
   PubMedGoogle Scholar
• Fukada K, Endo T, Yokoe M, et al. L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson’s disease. Med Hypotheses. 2013 Feb;80(2):209–212.
   PubMed Web of Science ®Google Scholar
• Hauser RA, Heritier S, Rowse GJ, et al. Droxidopa and reduced falls in a trial of Parkinson disease patients with neurogenic orthostatic hypotension. Clin Neuropharmacol. 2016 Sep-Oct;39(5):220–226.
   PubMed Web of Science ®Google Scholar
• de Vries OJ, Peeters G, Elders P, et al. The elimination half-life of benzodiazepines and fall risk: two prospective observational studies. Age Ageing. 2013 Nov;42(6):764–770.
   PubMed Web of Science ®Google Scholar
• Sako W, Murakami N, Motohama K, et al. The effect of istradefylline for Parkinson’s disease: a meta-analysis. Sci Rep. 2017 Dec 21;7(1):18018.
   PubMedGoogle Scholar
• Matsuura K, Kajikawa H, Tabei KI, et al. The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson’s disease. Neurosci Lett. 2018 Jan;662:158–161.
   Web of Science ®Google Scholar
• Iijima M, Orimo S, Terashi H, et al. Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson’s disease: a single-arm, open-label, prospective, multicenter study. Expert Opin Pharmacother. 2019 Aug;20(11):1405–1411.
   PubMed Web of Science ®Google Scholar
• Kogan M, McGuire M, Riley J. Deep Brain Stimulation for Parkinson Disease. Neurosurg Clin N Am. 2019 Apr;30(2):137–146.
   PubMed Web of Science ®Google Scholar
• Cossu G, Pau M. Subthalamic nucleus stimulation and gait in Parkinson’s Disease: a not always fruitful relationship. Gait Posture. 2017 Feb;52:205–210.
   PubMed Web of Science ®Google Scholar
• Odekerken VJ, Boel JA, Schmand BA, et al. GPi vs STN deep brain stimulation for Parkinson disease: three-year follow-up. Neurology. 2016 Feb 23;86(8):755–761.
   PubMed Web of Science ®Google Scholar
• Vercruysse S, Vandenberghe W, Munks L, et al. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson’s disease: a prospective controlled study. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):871–877.
   PubMed Web of Science ®Google Scholar
• Fasano A, Daniele A, Albanese A. Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation. Lancet Neurol. 2012 May;11(5):429–442.
   PubMed Web of Science ®Google Scholar
• Schlenstedt C, Shalash A, Muthuraman M, et al. Effect of high-frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson’s disease: a systematic review and meta-analysis. Eur J Neurol. 2017 Jan;24(1):18–26.
   PubMed Web of Science ®Google Scholar
• Schuepbach WM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013 Feb 14;368(7):610–622.
   PubMed Web of Science ®Google Scholar
• Barbe M, Tonder L, Sixel-Döring F, et al. The effect of early STN-DBS in PD patients on axial symptoms: a 2-year randomized controlled trial (EARLYSTIM-Gait analysis). Mov Dis. 2017;32(S2):1423.
   PubMedGoogle Scholar
• Karachi C, Cormier-Dequaire F, Grabli D, et al. Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson’s disease patients. Parkinsonism Relat Disord. 2019;62:91–97.
   PubMed Web of Science ®Google Scholar
• Scholten M, Klemt J, Heilbronn M, et al. Effects of subthalamic and nigral stimulation on gait kinematics in Parkinson’s disease. Front Neurol. 2017;8:543.
   PubMed Web of Science ®Google Scholar
• Lizarraga KJ, Jagid JR, Luca CC. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson’s disease: a randomized, blinded study. J Neurol. 2016 Aug;263(8):1652–1656.
   PubMed Web of Science ®Google Scholar
• Roper JA, Kang N, Ben J, et al. Deep brain stimulation improves gait velocity in Parkinson’s disease: a systematic review and meta-analysis. J Neurol. 2016 Jun;263(6):1195–1203.
   PubMed Web of Science ®Google Scholar
• Vallabhajosula S, Haq IU, Hwynn N, et al. Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson’s disease: a quantitative study. Brain Stimul. 2015 Jan-Feb;8(1):64–75.
   PubMed Web of Science ®Google Scholar
• Fasano A, Herzog J, Seifert E, et al. Modulation of gait coordination by subthalamic stimulation improves freezing of gait. Mov Disord. 2011 Apr;26(5):844–851.
   PubMed Web of Science ®Google Scholar
• Meoni S, Debu B, Pelissier P, et al. Asymmetric STN DBS for FOG in Parkinson’s disease: a pilot trial. Parkinsonism Relat Disord. 2019 Feb;63:94–99.
   PubMedGoogle Scholar
• Castrioto A, Lozano AM, Poon YY, et al. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol. 2011 Dec;68(12):1550–1556.
   PubMedGoogle Scholar
• Limousin P, Foltynie T. Long-term outcomes of deep brain stimulation in Parkinson disease. Nat Rev Neurol. 2019 Apr;15(4):234–242.
   PubMed Web of Science ®Google Scholar
• Fleury V, Pollak P, Gere J, et al. Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait. Mov Disord. 2016 Sep;31(9):1389–1397.
   PubMed Web of Science ®Google Scholar
• Moreau C, Defebvre L, Destee A, et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology. 2008 Jul 8;71(2):80–84.
   PubMed Web of Science ®Google Scholar
• Thobois S, Ardouin C, Lhommee E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain. 2010 Apr;133(Pt 4):1111–1127.
   PubMed Web of Science ®Google Scholar
• Pagonabarraga J, Kulisevsky J, Strafella AP, et al. Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol. 2015 May;14(5):518–531.
   PubMed Web of Science ®Google Scholar
• Weiss D, Wachter T, Breit S, et al. Involuntary eyelid closure after STN-DBS: evidence for different pathophysiological entities. J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):1002–1007.
   PubMed Web of Science ®Google Scholar
• Tommasi G, Krack P, Fraix V, et al. Effects of varying subthalamic nucleus stimulation on apraxia of lid opening in Parkinson’s disease. J Neurol. 2012 Sep;259(9):1944–1950.
   PubMed Web of Science ®Google Scholar
• St George RJ, Nutt JG, Burchiel KJ, et al. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology. 2010 Oct 5;75(14):1292–1299.
   PubMed Web of Science ®Google Scholar
• di Biase L, Fasano A. Low-frequency deep brain stimulation for Parkinson’s disease: great expectation or false hope? Mov Disord. 2016 Jul;31(7):962–967.
   PubMed Web of Science ®Google Scholar
• Zibetti M, Moro E, Krishna V, et al. Low-frequency subthalamic stimulation in Parkinson’s disease: long-term outcome and predictors. Brain Stimul. 2016 Sep-Oct;9(5):774–779.
   PubMed Web of Science ®Google Scholar
• Sidiropoulos C, Walsh R, Meaney C, et al. Low-frequency subthalamic nucleus deep brain stimulation for axial symptoms in advanced Parkinson’s disease. J Neurol. 2013 Sep;260(9):2306–2311.
   PubMed Web of Science ®Google Scholar
• Ricchi V, Zibetti M, Angrisano S, et al. Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. Brain Stimul. 2012 Jul;5(3):388–392.
   PubMed Web of Science ®Google Scholar
• Milosevic L, Kalia SK, Hodaie M, et al. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson’s disease. Brain. 2018 Jan 1;141(1):177–190.
   PubMedGoogle Scholar
• Thevathasan W, Coyne TJ, Hyam JA, et al. Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease. Neurosurgery. 2011 Dec;69(6):1248–1253. discussion 1254.
   PubMed Web of Science ®Google Scholar
• Ferraye MU, Debu B, Fraix V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson’s disease. Brain. 2010 Jan;133(Pt 1):205–214.
   PubMed Web of Science ®Google Scholar
• Thevathasan W, Debu B, Aziz T, et al. Pedunculopontine nucleus deep brain stimulation in Parkinson’s disease: a clinical review. Mov Disord. 2018 Jan;33(1):10–20.
   PubMed Web of Science ®Google Scholar
• Albin RL, Surmeier DJ, Tubert C, et al. Targeting the pedunculopontine nucleus in Parkinson’s disease: time to go back to the drawing board. Mov Disord. 2018 Dec;33(12):1871–1875.
   PubMed Web of Science ®Google Scholar
• Garcia-Rill E, Saper CB, Rye DB, et al. Focus on the pedunculopontine nucleus. Consensus review from the May 2018 brainstem society meeting in Washington, DC, USA. Clin Neurophysiol. 2019 Jun;130(6):925–940.
   PubMed Web of Science ®Google Scholar
• Hell F, Palleis C, Mehrkens JH, et al. Deep brain stimulation programming 2.0: future perspectives for target identification and adaptive closed loop stimulation. Front Neurol. 2019;10(314).
   Google Scholar
• Weiss D, Walach M, Meisner C, et al. Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial. Brain. 2013 Jul;136(Pt 7):2098–2108.
   PubMedGoogle Scholar
• Chastan N, Westby GW, Yelnik J, et al. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson’s disease. Brain. 2009 Jan;132(Pt 1):172–184.
   PubMed Web of Science ®Google Scholar
• Weiss D, Breit S, Wachter T, et al. Combined stimulation of the substantia nigra pars reticulata and the subthalamic nucleus is effective in hypokinetic gait disturbance in Parkinson’s disease. J Neurol. 2011 Jun;258(6):1183–1185.
   PubMed Web of Science ®Google Scholar
• Valldeoriola F, Munoz E, Rumia J, et al. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson’s disease: A pilot study. Parkinsonism Relat Disord. 2019;60:153–157.
   PubMed Web of Science ®Google Scholar
• de Andrade EM, Ghilardi MG, Cury RG, et al. Spinal cord stimulation for Parkinson’s disease: a systematic review. Neurosurg Rev. 2016 Jan;39(1):27–35. discussion 35.
   PubMed Web of Science ®Google Scholar
• Pinto de Souza C, Hamani C, Oliveira Souza C, et al. Spinal cord stimulation improves gait in patients with Parkinson’s disease previously treated with deep brain stimulation. Mov Disord. 2017 Feb;32(2):278–282.
   PubMed Web of Science ®Google Scholar
• Landi A, Trezza A, Pirillo D, et al. Spinal cord stimulation for the treatment of sensory symptoms in advanced Parkinson’s disease. Neuromodulation. 2013 May-Jun;16(3):276–279.
   PubMed Web of Science ®Google Scholar
• de Lima-Pardini AC, Coelho DB, Souza CP, et al. Effects of spinal cord stimulation on postural control in Parkinson’s disease patients with freezing of gait. eLife. 2018;7:e37727.
   Google Scholar
• Nieuwboer A, Dom R, De Weerdt W, et al. Electromyographic profiles of gait prior to onset of freezing episodes in patients with Parkinson’s disease. Brain. 2004 Jul;127(Pt 7):1650–1660.
   PubMedGoogle Scholar
• Edwards CA, Kouzani A, Lee KH, et al. Neurostimulation devices for the treatment of neurologic disorders. Mayo Clin Proc. 2017 Sep;92(9):1427–1444.
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003 Mar-Apr;24(2):197–211.
   PubMed Web of Science ®Google Scholar
• Engineer ND, Moller AR, Kilgard MP. Directing neural plasticity to understand and treat tinnitus. Hear Res. 2013 Jan;295:58–66.
   PubMed Web of Science ®Google Scholar
• Farrand AQ, Helke KL, Gregory RA, et al. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson’s disease. Brain Stimul. 2017 Nov - Dec;10(6):1045–1054.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Cao Z, Ma H, et al. Auricular vagus nerve stimulation exerts antiinflammatory effects and immune regulatory function in a 6-OHDA model of Parkinson’s disease. Neurochem Res. 2018 Nov;43(11):2155–2164.
   PubMed Web of Science ®Google Scholar
• Mondal B, Choudhury S, Chatterjee K, et al. Therapeutic effect of non-invasive vagus nerve stimulation in gait disturbance and freezing in Parkinson’s disease patients. Parkinsonism Relat Disord. 2018 Jan 1;46:e21.
   Web of Science ®Google Scholar
• Cakmak YO, Apaydin H, Kiziltan G, et al. Rapid Alleviation of Parkinson’s Disease Symptoms via Electrostimulation of Intrinsic Auricular Muscle Zones. Front Hum Neurosci. 2017 Jun 28;11(338):338.
   PubMedGoogle Scholar
• Kim YW, Shin IS, Moon HI, et al. Effects of non-invasive brain stimulation on freezing of gait in parkinsonism: a systematic review with meta-analysis. Parkinsonism Relat Disord. 2019 Feb 27. [Epub ahead of publication].
   Web of Science ®Google Scholar
• Lu C, Amundsen Huffmaster SL, Tuite PJ, et al. The effects of anodal tDCS over the supplementary motor area on gait initiation in Parkinson’s disease with freezing of gait: a pilot study. J Neurol. 2018 Sep;265(9):2023–2032.
   PubMed Web of Science ®Google Scholar
• Dagan M, Herman T, Harrison R, et al. Multitarget transcranial direct current stimulation for freezing of gait in Parkinson’s disease. Mov Disord. 2018 Apr;33(4):642–646.
   PubMed Web of Science ®Google Scholar
• Nonnekes J, Ruzicka E, Nieuwboer A, et al. Compensation strategies for gait impairments in Parkinson disease: a review. JAMA Neurol. 2019 Mar 25. [Epub ahead of publication].
   PubMed Web of Science ®Google Scholar
• Nieuwboer A, Kwakkel G, Rochester L, et al. Cueing training in the home improves gait-related mobility in Parkinson’s disease: the RESCUE trial. J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):134–140.
   PubMed Web of Science ®Google Scholar
• Lim I, van Wegen E, de Goede C, et al. Effects of external rhythmical cueing on gait in patients with Parkinson’s disease: a systematic review. Clin Rehabil. 2005 Oct;19(7):695–713.
   PubMed Web of Science ®Google Scholar
• Spaulding SJ, Barber B, Colby M, et al. Cueing and gait improvement among people with Parkinson’s disease: a meta-analysis. Arch Phys Med Rehabil. 2013 Mar;94(3):562–570.
   PubMed Web of Science ®Google Scholar
• Ghai S, Ghai I, Schmitz G, et al. Effect of rhythmic auditory cueing on parkinsonian gait: a systematic review and meta-analysis. Sci Rep. 2018 Jan 11;8(1):506.
   PubMedGoogle Scholar
• Nieuwboer A. Cueing for freezing of gait in patients with Parkinson’s disease: a rehabilitation perspective. Mov Disord. 2008;23(Suppl 2):S475–81.
   PubMedGoogle Scholar
• Heremans E, Nieuwboer A, Spildooren J, et al. Cognitive aspects of freezing of gait in Parkinson’s disease: a challenge for rehabilitation. J Neural Transm (Vienna). 2013 Apr;120(4):543–557.
   PubMed Web of Science ®Google Scholar
• Rochester L, Nieuwboer A, Baker K, et al. The attentional cost of external rhythmical cues and their impact on gait in Parkinson’s disease: effect of cue modality and task complexity. J Neural Transm (Vienna). 2007;114(10):1243–1248.
   PubMed Web of Science ®Google Scholar
• Espay AJ, Baram Y, Dwivedi AK, et al. At-home training with closed-loop augmented-reality cueing device for improving gait in patients with Parkinson disease. J Rehabil Res Dev. 2010;47(6):573–581.
   PubMed Web of Science ®Google Scholar
• Baram Y, Aharon-Peretz J, Badarny S, et al. Closed-loop auditory feedback for the improvement of gait in patients with Parkinson’s disease. J Neurol Sci. 2016 Apr;15(363):104–106.
   Google Scholar
• Mancini M, Smulders K, Harker G, et al. Assessment of the ability of open-and closed-loop cueing to improve turning and freezing in people with Parkinson’s disease. Sci Rep. 2018;8(1):12773.
   PubMedGoogle Scholar
• Barthel C, Nonnekes J, van Helvert M, et al. The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease. Neurology. 2018 Jan 9;90(2):e164–e171.
   PubMed Web of Science ®Google Scholar
• Barthel C, van Helvert M, Haan R, et al. Visual cueing using laser shoes reduces freezing of gait in Parkinson’s patients at home. Mov Disord. 2018 Oct;33(10):1664–1665.
   PubMed Web of Science ®Google Scholar
• Ginis P, Nackaerts E, Nieuwboer A, et al. Cueing for people with Parkinson’s disease with freezing of gait: a narrative review of the state-of-the-art and novel perspectives. Ann Phys Rehabil Med. 2018 Nov;61(6):407–413.
   PubMed Web of Science ®Google Scholar
• Spildooren J, Vercruysse S, Meyns P, et al. Turning and unilateral cueing in Parkinson’s disease patients with and without freezing of gait. Neuroscience. 2012 Apr;5(207):298–306.
   Google Scholar
• Ginis P, Heremans E, Ferrari A, et al. External input for gait in people with Parkinson’s disease with and without freezing of gait: one size does not fit all. J Neurol. 2017 Jul;264(7):1488–1496.
   PubMed Web of Science ®Google Scholar
• Spildooren J, Vercruysse S, Heremans E, et al. Influence of cueing and an attentional strategy on freezing of gait in Parkinson disease during turning. J Neurol Phys Ther. 2017 Apr;41(2):129–135.
   PubMed Web of Science ®Google Scholar
• Rovini E, Maremmani C, Cavallo F. How wearable sensors can support Parkinson’s disease diagnosis and treatment: a systematic review. Front Neurosci. 2017;11:555.
   PubMed Web of Science ®Google Scholar
• Arora S, Venkataraman V, Zhan A, et al. Detecting and monitoring the symptoms of Parkinson’s disease using smartphones: a pilot study. Parkinsonism Relat Disord. 2015 Jun;21(6):650–653.
   PubMed Web of Science ®Google Scholar
• Zhan A, Mohan S, Tarolli C, et al. Using smartphones and machine learning to quantify Parkinson disease severity: the mobile Parkinson disease score. JAMA Neurol. 2018 Jul 1;75(7):876–880.
   PubMed Web of Science ®Google Scholar
• Adams JL, Dinesh K, Xiong M, et al. Multiple wearable sensors in Parkinson and Huntington disease individuals: a pilot study in clinic and at home. Digital Biomarkers. 2017;1(1):52–63.
   PubMedGoogle Scholar
• Maetzler W, Domingos J, Srulijes K, et al. Quantitative wearable sensors for objective assessment of Parkinson’s disease. Mov Disord. 2013 Oct;28(12):1628–1637.
   PubMed Web of Science ®Google Scholar
• Kluge F, Gassner H, Hannink J, et al. Towards mobile gait analysis: concurrent validity and test-retest reliability of an inertial measurement system for the assessment of spatio-temporal gait parameters. Sensors (Basel). 2017 Jun 28;17(7):1522.
   Web of Science ®Google Scholar
• Schlachetzki JC, Barth J, Marxreiter F, et al. Wearable sensors objectively measure gait parameters in Parkinson’s disease. PloS One. 2017;12(10):e0183989.
   PubMed Web of Science ®Google Scholar
• Ellis RJ, Ng YS, Zhu S, et al. A validated smartphone-based assessment of gait and gait variability in Parkinson’s disease. PLoS One. 2015;10(10):e0141694.
   PubMed Web of Science ®Google Scholar
• Mancini M, Chiari L, Holmstrom L, et al. Validity and reliability of an IMU-based method to detect APAs prior to gait initiation. Gait Posture. 2016;43:125–131.
   PubMed Web of Science ®Google Scholar
• Mancini M, Horak FB, Zampieri C, et al. Trunk accelerometry reveals postural instability in untreated Parkinson’s disease. Parkinsonism Relat Disord. 2011 Aug;17(7):557–562.
   PubMed Web of Science ®Google Scholar
• Mancini M, Salarian A, Carlson-Kuhta P, et al. ISway: a sensitive, valid and reliable measure of postural control. J Neuroeng Rehabil. 2012 Aug;22(9):59.
   Google Scholar
• Ginis P, Nieuwboer A, Dorfman M, et al. Feasibility and effects of home-based smartphone-delivered automated feedback training for gait in people with Parkinson’s disease: a pilot randomized controlled trial. Parkinsonism Relat Disord. 2016;22:28–34.
   PubMed Web of Science ®Google Scholar
• Capecci M, Pepa L, Verdini F, et al. A smartphone-based architecture to detect and quantify freezing of gait in Parkinson’s disease. Gait Posture. 2016;50:28–33.
   PubMed Web of Science ®Google Scholar
• Mazilu S, Calatroni A, Gazit E, et al. Prediction of freezing of gait in Parkinson’s from physiological wearables: an exploratory study. IEEE J Biomed Health Inform. 2015 Nov;19(6):1843–1854.
   PubMed Web of Science ®Google Scholar
• Palmerini L, Rocchi L, Mazilu S, et al. Identification of characteristic motor patterns preceding freezing of gait in Parkinson’s disease using wearable sensors. Front Neurol. 2017;8:394.
   PubMed Web of Science ®Google Scholar
• Camps J, Samà A, Martín M, et al. Deep learning for freezing of gait detection in Parkinson’s disease patients in their homes using a waist-worn inertial measurement unit. Knowledge-Based Syst. 2018 January 01;139:119–131.
   Web of Science ®Google Scholar
• Xia Y, Zhang J, Ye Q, et al. Evaluation of deep convolutional neural networks for detection of freezing of gait in Parkinson’s disease patients. Biomed Signal Process Control. 2018;46:221–230.
   Web of Science ®Google Scholar
• Kim HB, Lee HJ, Lee WW, et al. Validation of freezing-of-gait monitoring using smartphone. Telemed E-Health. 2018 Nov;24(11):899–907.
   PubMed Web of Science ®Google Scholar
• Mazzetta I, Zampogna A, Suppa A, et al. Wearable sensors system for an improved analysis of freezing of gait in Parkinson’s disease using electromyography and inertial signals. Sensors (Basel). 2019 Feb 23;19(4).
   PubMed Web of Science ®Google Scholar
• Linares-Del Rey M, Vela-Desojo L, Cano-de la Cuerda R. Mobile phone applications in Parkinson’s disease: a systematic review. Neurologia. 2019 Jan - Feb;34(1):38–54.
   PubMed Web of Science ®Google Scholar
• Dockx K, Bekkers EM, Van Den Bergh V, et al. Virtual reality for rehabilitation in Parkinson’s disease. Cochrane Database Syst Rev. 2016 Dec;21(12):CD010760.
   Google Scholar
• Garcia-Agundez A, Folkerts AK, Konrad R, et al. Recent advances in rehabilitation for Parkinson’s disease with exergames: a systematic review. J Neuroeng Rehabil. 2019 Jan 29;16(1):17.
   PubMed Web of Science ®Google Scholar
• Ribas CG, Alves Da Silva L, Correa MR, et al. Effectiveness of exergaming in improving functional balance, fatigue and quality of life in Parkinson’s disease: a pilot randomized controlled trial. Parkinsonism Relat Disord. 2017;38:13–18.
   PubMed Web of Science ®Google Scholar
• Gandolfi M, Geroin C, Dimitrova E, et al. Virtual reality telerehabilitation for postural instability in Parkinson’s disease: a multicenter, single-blind, randomized, controlled trial. Biomed Res Int. 2017;2017:7962826.
   PubMed Web of Science ®Google Scholar
• Gomez-Jordana LI, Stafford J, Peper CLE, et al. Virtual footprints can improve walking performance in people with Parkinson’s disease. Front Neurol. 2018 Aug 17;9(681):681.
   PubMedGoogle Scholar
• Liao YY, Yang YR, Cheng SJ, et al. Virtual reality-based training to improve obstacle-crossing performance and dynamic balance in patients with Parkinson’s disease. Neurorehabil Neural Repair. 2015 Aug;29(7):658–667.
   PubMed Web of Science ®Google Scholar
• Mirelman A, Rochester L, Maidan I, et al. Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial. Lancet. 2016 Sep 17;388(10050):1170–1182.
   PubMed Web of Science ®Google Scholar
• Mirelman A, Rochester L, Reelick M, et al. V-TIME: a treadmill training program augmented by virtual reality to decrease fall risk in older adults: study design of a randomized controlled trial. BMC Neurol. 2013 Feb;6(13):15.
   Google Scholar
• Woollacott M, Shumway-Cook A. Attention and the control of posture and gait: a review of an emerging area of research. Gait Posture. 2002 Aug;16(1):1–14.
   PubMed Web of Science ®Google Scholar
• Alves G, Larsen JP, Emre M, et al. Changes in motor subtype and risk for incident dementia in Parkinson’s disease. Mov Disord. 2006 Aug;21(8):1123–1130.
   PubMed Web of Science ®Google Scholar
• Burn DJ, Rowan EN, Allan LM, et al. Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006 May;77(5):585–589.
   PubMed Web of Science ®Google Scholar
• Lundin-Olsson L, Nyberg L, Gustafson Y. “Stops walking when talking” as a predictor of falls in elderly people. Lancet. 1997 Mar 1;349(9052):617.
   PubMed Web of Science ®Google Scholar
• Smith E, Cusack T, Cunningham C, et al. The influence of a cognitive dual task on the gait parameters of healthy older adults: a systematic review and meta-analysis. J Aging Phys Act. 2017 Oct 1;25(4):671–686.
   PubMed Web of Science ®Google Scholar
• Marusic U, Verghese J, Mahoney JR. Cognitive-based interventions to improve mobility: a systematic review and meta-analysis. J Am Med Dir Assoc. 2018 Jun;19(6):484–491 e3.
   PubMed Web of Science ®Google Scholar
• Leung IH, Walton CC, Hallock H, et al. Cognitive training in Parkinson disease: a systematic review and meta-analysis. Neurology. 2015 Nov 24;85(21):1843–1851.
   PubMed Web of Science ®Google Scholar
• Wajda DA, Mirelman A, Hausdorff JM, et al. Intervention modalities for targeting cognitive-motor interference in individuals with neurodegenerative disease: a systematic review. Expert Rev Neurother. 2017 Mar;17(3):251–261.
   PubMed Web of Science ®Google Scholar
• Milman U, Atias H, Weiss A, et al. Can cognitive remediation improve mobility in patients with Parkinson’s disease? Findings from a 12 week pilot study. J Parkinsons Dis. 2014 Jan 1;4(1):37–44.
   PubMedGoogle Scholar
• Walton CC, Mowszowski L, Gilat M, et al. Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trial. NPJ Parkinson’s Dis. 2018;4(1):15.
   PubMedGoogle Scholar
• Fritz NE, Cheek FM, Nichols-Larsen DS. Motor-cognitive dual-task training in persons with neurologic disorders: a systematic review. J Neurol Phys Ther. 2015 Jul;39(3):142–153.
   PubMed Web of Science ®Google Scholar
• Strouwen C, Molenaar E, Munks L, et al. Training dual tasks together or apart in Parkinson’s disease: results from the DUALITY trial. Mov Disord. 2017 Aug;32(8):1201–1210.
   PubMed Web of Science ®Google Scholar
• Strouwen C, Molenaar E, Munks L, et al. Determinants of dual-task training effect size in parkinson disease: who will benefit most? J Neurol Phys Ther. 2019 Jan;43(1):3–11.
   PubMed Web of Science ®Google Scholar
• Marusic U, Grospretre S. Non-physical approaches to counteract age-related functional deterioration: applications for rehabilitation and neural mechanisms. Eur J Sport Sci. 2018 Jun;18(5):639–649.
   PubMed Web of Science ®Google Scholar
• Pelosin E, Avanzino L, Bove M, et al. Action observation improves freezing of gait in patients with Parkinson’s disease. Neurorehabil Neural Repair. 2010 Oct;24(8):746–752.
   PubMed Web of Science ®Google Scholar
• Caligiore D, Mustile M, Spalletta G, et al. Action observation and motor imagery for rehabilitation in Parkinson’s disease: a systematic review and an integrative hypothesis. Neurosci Biobehav Rev. 2017;72:210–222.
   PubMed Web of Science ®Google Scholar
• Pelosin E, Barella R, Bet C, et al. Effect of group-based rehabilitation combining action observation with physiotherapy on freezing of gait in parkinson’s disease. Neural Plast. 2018;2018:4897276.
   PubMed Web of Science ®Google Scholar
• Agosta F, Gatti R, Sarasso E, et al. Brain plasticity in Parkinson’s disease with freezing of gait induced by action observation training. J Neurol. 2017 Jan;264(1):88–101.
   PubMed Web of Science ®Google Scholar
• Jaywant A, Ellis TD, Roy S, et al. Randomized controlled trial of a home-based action observation intervention to improve walking in Parkinson disease. Arch Phys Med Rehabil. 2016 May;97(5):665–673.
   PubMed Web of Science ®Google Scholar
• Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson’s disease. Mov Disord. 2009 Nov 15;24(15):2175–2186.
   PubMed Web of Science ®Google Scholar
• Avanzino L, Lagravinese G, Abbruzzese G, et al. Relationships between gait and emotion in Parkinson’s disease: a narrative review. Gait Posture. 2018;65:57–64.
   PubMed Web of Science ®Google Scholar
• Banks SJ, Bayram E, Shan G, et al. Non-motor predictors of freezing of gait in Parkinson’s disease. Gait Posture. 2019;68:311–316.
   PubMed Web of Science ®Google Scholar
• Ehgoetz Martens KA, Lukasik EL, Georgiades MJ, et al. Predicting the onset of freezing of gait: a longitudinal study. Mov Disord. 2018 Jan;33(1):128–135.
   PubMed Web of Science ®Google Scholar
• Gilat M, Ligia Silva de Lima A, Bloem BR, et al. Freezing of gait: Promising avenues for future treatment. Parkinsonism Relat Disord. 2018;52:7–16.
   PubMed Web of Science ®Google Scholar
• Ehgoetz Martens KA, Shine JM, Walton CC, et al. Evidence for subtypes of freezing of gait in Parkinson’s disease. Mov Disord. 2018 Jul;33(7):1174–1178.
   PubMed Web of Science ®Google Scholar
• Wijemanne S, Jankovic J. Hand, foot, and spine deformities in parkinsonian disorders. J Neural Transm (Vienna). 2019 Mar;126(3):253–264.
   PubMed Web of Science ®Google Scholar